NIH's SMaHT Network benchmarks sequencing methods for rare somatic mutations in Cell
NIH's SMaHT Network has published its first benchmarking study in Cell, calibrating sequencing methods for rare somatic mutations. The researchers say the methods are more sensitive and specific than before, and call the work foundational for disease studies beyond cancer.
The Scientist · Science desk
What happened
- Researchers at Baylor College of Medicine's Human Genome Sequencing Center led three grant projects to build the tools for studying these somatic changes.
- Sedlazeck and Grochowski led work on large somatic structural variants, and Rui Chen led analysis of single-cell data.
- Margaret Goodell and Jacey Pridgen wrote a commentary in the same issue of Cell covering this paper and other upcoming network papers.
Why it matters
- What's now possible capability If the duplex methods hold up in other labs, a mutation carried by a single DNA molecule in bulk tissue becomes a routine measurement.
- What it sets up precedent Goodell and Pridgen frame the work as a baseline of 'normal', so later disease studies will be judged against the network's calibration.
- What it limits constraint The paper is groundwork. The disease studies that would use these methods are still upcoming, so no disease claim rests on them yet.
- What doesn't add up contradiction The commentary credits the network with a first body-wide map, but it covers several papers, and this one is titled as a benchmark of detection.
The verdict on the methods comes from the people who built them. They say the tools detect different types of somatic mutation with greater sensitivity and specificity than before [9]. The thing this doesn't tell you is how rare a mutation can be before each method stops seeing it, or how often a method calls one that is not there. Any such figures would be in the Cell paper by Abyzov and colleagues [7].
There is probably no single number to expect, either. The network built tools for several classes of mutation. Duplex sequencing targets mutations in single DNA molecules, taken from bulk tissue or from single cells [3]. Separate methods target large structural variants, and a third strand of work analyses single-cell data [4]. A point change in one molecule and a rearrangement of a long stretch of DNA are different measurements, and we'd expect the paper to score each one separately.
The researchers say the combined toolkit gives a complete and integrated view of the normal patterns of somatic mosaicism [12]. The accompanying commentary by Margaret Goodell and Jacey Pridgen goes further. "Every cell in the human body carries its own genome, shaped by mutations acquired over a lifetime, yet this vast somatic variation has been nearly impossible to measure," they wrote. "The SMaHT Network now delivers benchmarked tools and the first body-wide map of somatic mosaicism, establishing a baseline of 'normal' against which its roles in development, aging and disease can finally be tested." [10]
That commentary summarizes this paper and other upcoming network papers [6], while the benchmarking paper's own title is about detection [7]. We would not credit the body-wide map to this study alone.
No disease finding rests on the work yet. The study is described as foundational for upcoming disease studies [11], and the account says somatic mutations are emerging as the seeds of common noncancerous diseases [8]. The account centres on Baylor's contributions [2], and the paper's byline is the network as a whole, with contributors listed in the paper [5].
What to watch
- Sensitivity and specificity figures for each mutation class in the Cell paper, and whether other labs reproduce them.
- The other upcoming SMaHT Network papers the commentary refers to, which would carry the body-wide map.
- The first disease study to use the benchmarked methods on noncancerous disease.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence40
- Adoption
- Insufficient
- Hype gap+25
- Incentives
- Insufficient
- Confidence45
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
The Somatic Mosaicism across Human Tissues (SMaHT) Network, a National Institutes of Health Common Fund initiative to catalog the normal processes of somatic mutation, has published its first comprehensive benchmarking study in the journal Cell.
- [2]
Researchers at Baylor College of Medicine's Human Genome Sequencing Center led three grant projects to develop tools for studying somatic changes.
- [3]
Baylor scientists led by Chenghang (Chuck) Zong, Harshavardhan Doddapaneni and Richard Gibbs made major contributions to new 'duplex' DNA sequencing methods that can accurately detect somatic mutations present in single DNA molecules isolated from bulk tissue samples or single cells.
- [4]
Fritz Sedlazeck and Christopher Grochowski led work on new ways to detect large DNA changes called somatic structural variants, and Rui Chen led analysis of data from single cells.
- [5]
The paper carries a banner authorship of 'The Somatic Mutation across Human Tissues Network', with the full list of contributors in the paper.
- [6]
Also in the same issue of Cell, Margaret A. Goodell and Jacey R. Pridgen wrote an accompanying commentary summarizing the findings of these and other upcoming SMaHT Network papers and their implications for understanding aging and human health.
- [7]
The benchmarking paper is Alexej Abyzov et al., 'Comprehensive benchmarking of somatic mutation detection by the SMaHT Network', Cell (2026), DOI 10.1016/j.cell.2026.09.037; the commentary is Jacey R. Pridgen et al., 'Charting the silent variation within us', Cell (2026), DOI 10.1016/j.cell.2026.09.046.
- [8]
Somatic mutations, the DNA changes that occur as bodies grow and age, hold a key to cancer and are emerging as the seeds of a wide range of common, noncancerous diseases.
- [9]
The researchers developed and calibrated new sequencing technologies, experimental approaches and computational methods that they say detect different types of somatic mutations with greater sensitivity and specificity than ever before.
- [10]
Goodell and Pridgen wrote: "Every cell in the human body carries its own genome, shaped by mutations acquired over a lifetime, yet this vast somatic variation has been nearly impossible to measure. The SMaHT Network now delivers benchmarked tools and the first body-wide map of somatic mosaicism, establishing a baseline of 'normal' against which its roles in development, aging and disease can finally be tested."
- [11]
The study is foundational for upcoming disease studies probing somatic genetic changes.
- [12]
The new methods enable a complete and integrated view of the normal patterns of somatic mosaicism and pave the road for studying the role of somatic mutations in common human diseases.
Get this ledger inside ChatGPT. Ask about any of our stories and the answer brings its figure, each claim’s verdict and the sources. Free, no account.
Sources
1 independent publisher whose own reporting we read for this story.
- phys.orgNew DNA sequencing methods detect rare mutations acquired as bodies grow and age
1 article · October 15, 2026
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.